Company / Revenue per Share
AMICUS THERAPEUTICS, INC. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$2.12
FY2025
5-year range
$1.17 / $2.12
FY2021-FY2025
Trend
+17.9%
vs FY2024
Sector context
#85 of 154
Health Care
What the data says
At $2.12, AMICUS THERAPEUTICS, INC.'s revenue per share ranks #85 of 154 in the Health Care sector. Revenue per Share has increased for 8 consecutive years, from $0.04 in FY2016 to $2.12 in FY2025.
Based on SEC 10-K filings.
2.12 in FY2025 with a 5-year CAGR of +16.0%.
Improved from $1.42 to $2.12 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +16.0%
- 10-Year CAGR
- -
Sector benchmark
#85 of 154 in Health CareTop 55% of 154This company $2.12 Sector average $15.09
▼
-85.9% below sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s revenue per share has grown for 6 consecutive years.
- In FY2025, revenue per share increased 17.9% year-over-year.
- Ranks #85 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.12 | +17.9% |
| FY2024 | $1.80 | +26.7% |
| FY2023 | $1.42 | +20.4% |
| FY2022 | $1.18 | +1.3% |
| FY2021 | $1.17 | +15.7% |
| FY2020 | $1.01 | +33.0% |
| FY2019 | $0.76 | - |
| FY2018 | - | - |
| FY2017 | $0.26 | +552.6% |
| FY2016 | $0.04 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026